Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Also Read: Class 3 Obesity Life Expectancy: What You Need to Know Other Therapeutic Benefits of GLP-1 Medications As research continues, experts are finding that these medications may help far beyond diabetes and obesity
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive tirzepatide or placebo administered subcutaneously once a week Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
Clinical data show that patients often regain weight after discontinuing use
Therapeutic Advances in Endocrinology and Metabolism, 2024
This process called catabolism reduces lean mass, lowers resting metabolic rate, and makes weight regain more likely after treatment ends
